Pacira to Report 2023 Financial Results on Thursday February 29, 2024
February 22 2024 - 8:00AM
Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will
report its fourth quarter and year ended December 31, 2023
financial results before the open of the U.S. markets on Thursday
February 29, 2024. Following the release, the company will host a
live conference call and webcast at 8:30 a.m. ET.
For listeners who wish to participate in the
question and answer session via telephone, please pre-register
here. All registrants will receive dial-in information and a PIN
allowing them to access the live call. In addition, a live audio of
the conference call will be available as a webcast. Interested
parties can access the event through the “Events” page on the
Pacira website at investor.pacira.com. For those unable to
participate in the live call, a replay of the webcast will be
available on the Pacira website for approximately two weeks
following the call.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to
providing a non-opioid option to as many patients as possible to
redefine the role of opioids as rescue therapy only. The company is
also developing innovative interventions to address debilitating
conditions involving the sympathetic nervous system, such as
cardiac electrical storm, chronic pain, and spasticity. Pacira has
three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine
liposome injectable suspension), a long-acting, local analgesia
currently approved for postsurgical pain management; ZILRETTA®
(triamcinolone acetonide extended-release injectable suspension),
an extended-release, intra-articular, injection indicated for the
management of osteoarthritis knee pain; and ioveraº®, a novel,
handheld device for delivering immediate, long-acting, drug-free
pain control using precise, controlled doses of cold temperature to
a targeted nerve. To learn more about Pacira, including the
corporate mission to reduce overreliance on opioids, visit
www.pacira.com.
Investor Contact:
Pacira BioSciences, Inc.
Christian Pedetti, (973) 254-4387
Christian.Pedetti@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Jul 2023 to Jul 2024